Detail page

Knowledge Web

Person

Michael Roden (1961-)

Arzt

Name	Michael Roden
Time	1961- (Date of birth and death)
Place	Österreich Deutschland
Gender	männlich
Academic degree	Prof. Dr. med. Dr. h.c.
Profession	Arzt (characteristic profession) Internist Endokrinologe Diabetologe Hochschullehrer
Variant	M. Roden
Related	Deutsches Diabetes-Zentrum Deutsches Zentrum für Diabetesforschung Universitätsklinikum Düsseldorf Heinrich-Heine-Universität Düsseldorf Universitätsklinikum Düsseldorf. Klinik für Endokrinologie und Diabetologie
Further information	Prof., Medizinische Abteilung, Hanusch-Krankenhaus, Karl-Landsteiner-Institut für Endokrinologie und Stoffwechselkrankheiten
Source	Wikipedia: https://de.wikipedia.org/w/index.php?title=Michael_Roden&oldid=206457255 (Stand: 20.01.2021)
Record type	Person
GND-Identifier	130812773
Record ID	130812773
Involved in show all PTA-DFS study: design of a randomised controlled trial assessing the effects of early percutaneous transluminal angioplasty on the healing of diabetic foot ulcers in persons with type 2 diabetes Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG) Prevention of type 2 diabetes through prediabetes remission without weight loss Diabetes mellitus as a multisystem disease: understanding subtypes, complications, and the link with steatotic liver diseases in humans Hypertension and kidney dysfunction despite long-term remission of Cushing’s syndrome Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes Prediabetes Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters Diabetes und metabolische-Dysfunktion-assoziierte steatotische Lebererkrankung The People-First Liver Charter 31P-MRS saturation transfer for assessing human hepatic ATP synthesis at clinical field strength Cross-sectional association between the isocaloric replacement of carbohydrates with protein and fat in relation to fat compartments distribution and hepatic lipid content in recent-onset type 1 and type 2 diabetes LEOPARD: missing view completion for multi-timepoint omics data via representation disentanglement and temporal knowledge transfer Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes Phenotype-based clusters, inflammation and cardiometabolic complications in older people before the diagnosis of type 2 diabetes: KORA F4/FF4 cohort study Associations of carbohydrate quality and cardiovascular risk factors vary among diabetes subtypes A web-based application for diabetes subtyping: The DDZ Diabetes-Cluster-Tool Associations between biomarkers of inflammation and depressive symptoms—potential differences between diabetes types and symptom clusters of depression Endokrinologische Notfälle Blauer Teil: Organ- und Themenbezogene Krankheitsbilder: Diabetes mellitus/Adipositas Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy Subphenotypes of adult‐onset diabetes: data‐driven clustering in the population‐based KORA cohort Interpretable multimodal machine learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy The potential of precision diabetology for type 2 diabetes treatment—evidence from a meta-regression for all-cause mortality from large cardiovascular outcome trials The Journey to a FAIR CORE DATA SET for Diabetes Research in Germany Type 2 diabetes across populations of different ancestry: deconstructing the genomic landscape A global initiative to deliver precision health in diabetes Semaphorin-3A regulates liver sinusoidal endothelial cell porosity and promotes hepatic steatosis Diabetes und Fettleber Sex-specific trends in incidence of first myocardial infarction among people with and without diabetes between 1985 and 2016 in a German region Diabetes and pulmonary infection: how hyperglycaemia shapes the immune system Ursachen, Klinik und Folgen der Insulinresistenz bei Typ-2-Diabetes Absolute treatment effects of novel antidiabetic drugs on a composite renal outcome: meta-analysis of digitalized individual patient data Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) : März 2024 – AWMF-Registernummer: 021–025 Omentin Increases Glucose Uptake, but Not Insulin Sensitivity in Human Myotubes Dependent on Extracellular Lactotransferrin Diabetes and Fatty Liver Diabetes und Metabolische Dysfunktion-assoziierte Steatotische Lebererkrankung Precise glucose measurement in sodium fluoride-citrate plasma affects estimates of prevalence in diabetes and prediabetes Leitlinienempfehlungen für den klinischen Alltag: die 2023-ESC-Leitlinien zum Management kardiovaskulärer Erkrankungen bei Diabetes mellitus Risiken diabetesassoziierter Komorbiditäten in Subgruppen des Typ-2-Diabetes Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: the KORA F4 study Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: the KORA F4 study Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study Quantitative assessment of angioplasty-induced vascular inflammation with 19F cardiovascular magnetic resonance imaging Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets The effects of extracellular vesicles and their cargo on metabolism and its adaptation to physical exercise in insulin resistance and type 2 diabetes How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction Diabetes und Fettleber Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023) Injektionstherapie (GLP1-Rezeptor Agonisten und Insulin) bei Typ 2 Diabetes mellitus (Update 2023) Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023) Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023) Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders Association of Aldosterone with Mortality in the General Population Mit präzisen Ansätzen die „patient journey“ optimieren : Neue Wege der gezielteren Diabetesprävention und -therapie

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Michael Roden (1961-)

PTA-DFS study: design of a randomised controlled trial assessing the effects of early percutaneous transluminal angioplasty on the healing of diabetic foot ulcers in persons with type 2 diabetes

Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG)

Prevention of type 2 diabetes through prediabetes remission without weight loss

Diabetes mellitus as a multisystem disease: understanding subtypes, complications, and the link with steatotic liver diseases in humans

Hypertension and kidney dysfunction despite long-term remission of Cushing’s syndrome

Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes

Prediabetes

Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters

Diabetes und metabolische-Dysfunktion-assoziierte steatotische Lebererkrankung

The People-First Liver Charter

31P-MRS saturation transfer for assessing human hepatic ATP synthesis at clinical field strength

Cross-sectional association between the isocaloric replacement of carbohydrates with protein and fat in relation to fat compartments distribution and hepatic lipid content in recent-onset type 1 and type 2 diabetes

LEOPARD: missing view completion for multi-timepoint omics data via representation disentanglement and temporal knowledge transfer

Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes

Phenotype-based clusters, inflammation and cardiometabolic complications in older people before the diagnosis of type 2 diabetes: KORA F4/FF4 cohort study

Associations of carbohydrate quality and cardiovascular risk factors vary among diabetes subtypes

A web-based application for diabetes subtyping: The DDZ Diabetes-Cluster-Tool

Associations between biomarkers of inflammation and depressive symptoms—potential differences between diabetes types and symptom clusters of depression

Endokrinologische Notfälle

Blauer Teil: Organ- und Themenbezogene Krankheitsbilder: Diabetes mellitus/Adipositas

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

Subphenotypes of adult‐onset diabetes: data‐driven clustering in the population‐based KORA cohort

Interpretable multimodal machine learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy

The potential of precision diabetology for type 2 diabetes treatment—evidence from a meta-regression for all-cause mortality from large cardiovascular outcome trials

The Journey to a FAIR CORE DATA SET for Diabetes Research in Germany

Type 2 diabetes across populations of different ancestry: deconstructing the genomic landscape

A global initiative to deliver precision health in diabetes

Semaphorin-3A regulates liver sinusoidal endothelial cell porosity and promotes hepatic steatosis

Diabetes und Fettleber

Sex-specific trends in incidence of first myocardial infarction among people with and without diabetes between 1985 and 2016 in a German region

Diabetes and pulmonary infection: how hyperglycaemia shapes the immune system

Ursachen, Klinik und Folgen der Insulinresistenz bei Typ-2-Diabetes

Absolute treatment effects of novel antidiabetic drugs on a composite renal outcome: meta-analysis of digitalized individual patient data

Omentin Increases Glucose Uptake, but Not Insulin Sensitivity in Human Myotubes Dependent on Extracellular Lactotransferrin

Diabetes and Fatty Liver

Diabetes und Metabolische Dysfunktion-assoziierte Steatotische Lebererkrankung

Precise glucose measurement in sodium fluoride-citrate plasma affects estimates of prevalence in diabetes and prediabetes

Leitlinienempfehlungen für den klinischen Alltag: die 2023-ESC-Leitlinien zum Management kardiovaskulärer Erkrankungen bei Diabetes mellitus

Risiken diabetesassoziierter Komorbiditäten in Subgruppen des Typ-2-Diabetes

Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: the KORA F4 study

Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: the KORA F4 study

Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study

Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study

Quantitative assessment of angioplasty-induced vascular inflammation with 19F cardiovascular magnetic resonance imaging

Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase

Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

The effects of extracellular vesicles and their cargo on metabolism and its adaptation to physical exercise in insulin resistance and type 2 diabetes

How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials

Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis

SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction

Diabetes und Fettleber

Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023)

Injektionstherapie (GLP1-Rezeptor Agonisten und Insulin) bei Typ 2 Diabetes mellitus (Update 2023)

Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023)

Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023)

Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders

Association of Aldosterone with Mortality in the General Population

Mit präzisen Ansätzen die „patient journey“ optimieren : Neue Wege der gezielteren Diabetesprävention und -therapie